ArticleInternational journal of oncology2013

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer.

Chang-Ηua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.